Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;54(9):2295-306.
doi: 10.1194/jlr.R032946. Epub 2013 Mar 15.

Mechanisms for the prevention of vitamin E excess

Affiliations
Review

Mechanisms for the prevention of vitamin E excess

Maret G Traber. J Lipid Res. 2013 Sep.

Abstract

The liver is at the nexus of the regulation of lipoprotein uptake, synthesis, and secretion, and it is the site of xenobiotic detoxification by cytochrome P450 oxidation systems (phase I), conjugation systems (phase II), and transporters (phase III). These two major liver systems control vitamin E status. The mechanisms for the preference for α-tocopherol relative to the eight naturally occurring vitamin E forms largely depend upon the liver and include both a preferential secretion of α-tocopherol from the liver into the plasma for its transport in circulating lipoproteins for subsequent uptake by tissues, as well as the preferential hepatic metabolism of non-α-tocopherol forms. These mechanisms are the focus of this review.

Keywords: alpha-tocopherol; lipoprotein metabolism; xenobiotic metabolism.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Vitamin E structures. (A) α-Tocopherol-related structures. From top to bottom: RRR-α-tocopherol with indicated stereochemistry on the side chain and at position 2, (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol; α-tocotrienol, R-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chroman-6-ol; α-CMBHC: 2,5,7,8-tetramethyl-2(2’-carboxymethylbutyl)-6-hydroxychroman, or 5-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)-2-methyl-pentanoic acid; α-CEHC: 2,5,7,8-tetramethyl-2(2’-carboxyethyl)-6-hydroxychroman, or 3-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)propanoic acid. (B) Various forms of vitamin E and its metabolites. The chromanol ring illustrated at the bottom indicates the position of the substituents at positions 5, 7, and 8 and the side-chain location. The table indicates the various substituents for each α, β, γ, and δ, as well as the side chains for tocopherols, tocotrienols, and CEHCs.
Scheme 1.
Scheme 1.
Relationship between vitamin E in diet, circulation, liver, and excretion. The α-tocopherol and α-CEHC are shown in a rose color, with higher concentrations indicated by darker colors. For all panels, as the vitamin E intake moves from low (<5 mg/day), to adequate (10–50 mg/day), to very high (>1,000 mg/day), the intensity of the color increases. Components with no color change (e.g., α-TTP) do not vary with vitamin E intake. Note that OATP varies inversely with vitamin E intake.

Similar articles

Cited by

References

    1. Institute of Medicine. 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC.
    1. Vivekananthan D. P., Penn M. S., Sapp S. K., Hsu A., Topol E. J. 2003. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 361: 2017–2023. - PubMed
    1. Bjelakovic G., Nikolova D., Gluud L. L., Simonetti R. G., Gluud C. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 297: 842–857. - PubMed
    1. Miller E. R., 3rd, Paston-Barriuso R., Dalal D., Riemersma R. A., Appel L. J., Guallar E. 2005. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142: 37–46. - PubMed
    1. Abner E. L., Schmitt F. A., Mendiondo M. S., Marcum J. L., Kryscio R. J. 2011. Vitamin E and all-cause mortality: a meta-analysis. Curr. Aging Sci.4: 158–170.

Publication types